-
Je něco špatně v tomto záznamu ?
Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer
K. Vokacova, A. Landecka, S. Selvi, J. Horak, V. Novosadova, K. Manakova, M. Levy, V. Vymetalkova
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
39275807
DOI
10.1093/mutage/geae023
Knihovny.cz E-zdroje
- MeSH
- chemorezistence * genetika MeSH
- fluoruracil * terapeutické užití farmakologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA * genetika krev MeSH
- nádorové biomarkery genetika krev MeSH
- nádory tračníku * genetika farmakoterapie krev patologie MeSH
- prognóza MeSH
- regulace genové exprese u nádorů MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Chemoresistance represents a major issue affecting cancer therapy efficacy. Because microRNAs (miRNAs) regulate gene expression on multiple levels, their role in chemoresistance development is reasonably certain. In our previous study, miR-122-5p and miR-142-5p were identified as diagnostic, prognostic, and predictive biomarkers for primary and metastatic rectal cancer. The aim of the present study was to investigate whether these miRNAs can also reflect the disease course of patients with colon cancer (CC). Further, we focused on a deeper understanding of their involvement in 5-fluorouracil (5-FU) chemoresistance development.
1st Medical Faculty Charles University Prague 142 20 Czech Republic
3rd Faculty of Medicine Charles University Ruska 87 Prague 10000 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009493
- 003
- CZ-PrNML
- 005
- 20250429134737.0
- 007
- ta
- 008
- 250415s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/mutage/geae023 $2 doi
- 035 __
- $a (PubMed)39275807
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vokacova, Klara $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic $u 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, 142 20, Czech Republic
- 245 10
- $a Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer / $c K. Vokacova, A. Landecka, S. Selvi, J. Horak, V. Novosadova, K. Manakova, M. Levy, V. Vymetalkova
- 520 9_
- $a Chemoresistance represents a major issue affecting cancer therapy efficacy. Because microRNAs (miRNAs) regulate gene expression on multiple levels, their role in chemoresistance development is reasonably certain. In our previous study, miR-122-5p and miR-142-5p were identified as diagnostic, prognostic, and predictive biomarkers for primary and metastatic rectal cancer. The aim of the present study was to investigate whether these miRNAs can also reflect the disease course of patients with colon cancer (CC). Further, we focused on a deeper understanding of their involvement in 5-fluorouracil (5-FU) chemoresistance development.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mikro RNA $x genetika $x krev $7 D035683
- 650 12
- $a nádory tračníku $x genetika $x farmakoterapie $x krev $x patologie $7 D003110
- 650 12
- $a chemorezistence $x genetika $7 D019008
- 650 12
- $a fluoruracil $x terapeutické užití $x farmakologie $7 D005472
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a nádorové biomarkery $x genetika $x krev $7 D014408
- 650 _2
- $a prognóza $7 D011379
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Landecka, Aneta $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic
- 700 1_
- $a Selvi, Saba $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, 128 00, Czech Republic
- 700 1_
- $a Horak, Josef $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic $u Third Faculty of Medicine, Charles University, Ruska 87, Prague, 10000, Czech Republic
- 700 1_
- $a Novosadova, Vendula $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Prague, 252 50, Czech Republic
- 700 1_
- $a Manakova, Katerina $u 1st Medical Faculty, Charles University, Prague, 142 20, Czech Republic
- 700 1_
- $a Levy, Miroslav $u First Faculty of Medicine, Department of Surgery, Charles University and Thomayer Hospital, Prague, 140 59, Czech Republic
- 700 1_
- $a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic $1 https://orcid.org/0000000168706788 $7 xx0102721
- 773 0_
- $w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 40, č. 1 (2025), s. 80-86
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39275807 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134733 $b ABA008
- 999 __
- $a ok $b bmc $g 2311089 $s 1246574
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 40 $c 1 $d 80-86 $e 20250315 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
- LZP __
- $a Pubmed-20250415
